Search Results Search Sort by RelevanceMost Recent Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708. Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements. Policy Forum Jun 2015 Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates Michael Krawitz The new Veterans Health Administration policy on the use of medical marijuana was brought about by patient advocacy in 2010. AMA J Ethics. 2015;17(6):558-561. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Podcast Dec 2016 Ethics Talk: The Limits and Possibilities of Biomedical Enhancement - An Interview with Dr. Allen Buchanan This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.
Policy Forum Jun 2015 Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates Michael Krawitz The new Veterans Health Administration policy on the use of medical marijuana was brought about by patient advocacy in 2010. AMA J Ethics. 2015;17(6):558-561. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506.